Biobanking Market - Industry analysis, Trends, Estimation & Forecast, 2016 - 2024

November 2017

 ERC 6393

Biobanking is the collection and preservation of biological material used for diagnosis, biodiversity studies, and research. Biobanks play a fundamental role in supporting biomedical research studies, developing personalized medicine and for maintaining and updating age demographic databases. Biological samples such as purified saliva, blood, plasma, DNA samples are collected systematically from patients and various other donors. The rising incidents of blood disorders and the surging demand for various types of blood products across the globe, are driving the growth of biobanking market.

Market Determinants

The key factors driving the growth of global biobanking market are the advances in drug discovery & regenerative medicine, and rising investments from the government & non-government organizations. NIH is the major source of funding and facilitator for many Biobanks across the U.S. Moreover, rising demand for personalized medicines and the growing trend of preserving cord blood stem cells of newborns are also driving the market growth. On the other hand,, the stringent regulations regarding biospecimen sample procurement and costly techniques involved act as the major hurdles in the growth of the market. However, increasing government initiatives and rising interest of pharmaceutical & biotechnology companies in biobanking sector are expected to create huge opportunities for the growth of market in the coming years.

Segment Analysis

The global biobanking market is segmented on the basis of product and service, sample type, application, and geography. By product and service, the market is segmented into consumables, services, equipment, and software. On the basis of sample type, the market is segmented into human tissues, nucleic acids, cell lines, blood products, biological fluids, and human waste products. By application, the market is segmented into regenerative medicine, life science research, and clinical research. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. In terms of region, North America is a strong market due to factors such as increasing research activities in regenerative medicine and cell & gene therapy, increasing number of biotechnology and pharmaceutical companies, and rising investments in genomics and proteomics research. Biobanks currently exist in every continent, including Antarctica, with most located in North America and Europe. Moreover, this landscape is expanding rapidly, as countries, including China, Gambia, Jordan, Mexico and South Africa, are placing great efforts into building their own biobanks and biobanking networks.

Some key vendors in the market are Promega Corporation, Tecan Group Ltd., Qiagen N.V., Hamilton Company, Merck KGaA, Brooks Automation, TTP Labtech Ltd, VWR Corporation, Chart Industries Inc., Becton, Dickinson and Company, LVL Technologies GmbH & Co. KG, Greiner Bio-One, Biokryo GmbH, Biobank AS, Thermo Fisher Scientific Inc., Biorep Technologies Inc., Cell & Co Bioservices, RUCDR infinite biologics, Worthington Industries, Modul-Bio, and LabVantage Solutions Inc. In September 2017, Thermo Fisher Scientific has signed an agreement with the Institute of Pathology Heidelberg (IPH) to establish its Center of Molecular Pathology at Heidelberg University Hospital as the newest member of the Next Generation Sequencing Companion Dx Center of Excellence Program (COEP).


BIOBANKING MARKET SEGMENTATION

By Product and service
• Consumables
• Services
• Equipment
• Software

By Sample Type
• Human Tissues
• Nucleic Acids
• Cell Lines
• Blood Products
• Biological Fluids
• Human Waste Products

By Application
• Regenerative Medicine
• Life Science Research
• Clinical Research

By Geography
• North America
o U.S.
o Canada
• Europe
o France
o Germany
o Italy
o Netherlands
o U.K.
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o Rest of Asia-Pacific
• Rest of the World
o Latin America
o Middle East
o Africa

KEY MARKET PLAYERS

• Promega Corporation
• Tecan Group Ltd.
• Qiagen N.V.
• Hamilton Company
• Merck KGaA
• Brooks Automation
• TTP Labtech Ltd
• VWR Corporation
• Chart Industries Inc.
• Becton
• Dickinson and Company
• LVL Technologies GmbH & Co. KG
• Greiner Bio-One
• Biokryo GmbH
• Biobank AS
• Thermo Fisher Scientific Inc.
• Biorep Technologies Inc.
• Cell & Co Bioservices
• RUCDR infinite biologics
• Worthington Industries
• Modul-Bio
• LabVantage Solutions Inc.

Please fill in the form below to Request for Customized Report

Refresh Captcha

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.


Refresh Captcha

    What Information does this report contain?

    • What was the market size of the Biobanking Market in 2016 and the expected market size by 2024, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2016 - 2024)?
    • Which are the leading companies in the Biobanking Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +1-(908) 379-7709


  help@esticastresearch.com